ea0032p1059 | Thyroid (non-cancer) | ECE2013
Drbalova Karolina
, Vodak Miroslav
, Nyvltova Monika
, Tuckova Inna
, Hill Martin
Levothyroxine suppression therapy, i.e. keeping the TSH value below 0.3 mIU/l with the aim to reduce the total thyroidal tissue or nodule volume, is an arguable and controversial issue not only due to the effect upon nodule volume but also because of the extent of necessary suppression, the effect of incomplete suppression, long-time therapeutic effects and risk of cardiovascular problems and osteoporosis.The incidence of nodular alterations rises with a...